| Roberto De Giorgio, LAMFT | |
|
934 S Main St, Layton, UT 84041-7135 | |
| (801) 233-8607 | |
| Not Available |
| Full Name | Roberto De Giorgio |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 934 S Main St, Layton, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639568967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 3426353904 (Utah) | Primary |
| Entity Name | Davis Behavioral Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770641672 PECOS PAC ID: 7416861919 Enrollment ID: O20031118000909 |
News Archive
Vitamin D deficiency - which is traditionally associated with bone and muscle weakness - may also increase the risk of cardiovascular disease (CVD).
Synexus has completed a phase II study for the European biotech, Creabilis, recruiting 26 patients in the UK to the psoriasis trial of its CT327 lead product in just 2 weeks, as part of an international proof-of-concept study. The company delivered the targeted number of patients well within the agreed timelines and budget.
In the study, the scientists screened known drugs and identified small molecules that could replace conventional reprogramming genes, which can have dangerous side effects.
Competitive Technologies, Inc. today announced the presentation of results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy using CTT's Calmare Pain Therapy Treatment. A three-hour discussion led by principal investigator, Thomas J. Smith, M.D., Endowed Chair of Palliative Care Research and Medical Director of the Thomas Palliative Care Unit Virginia Commonwealth University's Massey Cancer Center, at the American Society of Clinical Oncology Annual Meeting, cited results of the study.
According to the Centers for Disease Control and Prevention, cataracts are the number one cause of vision loss in the United States. Nearly 22 million Americans age 40 and over have cataracts, while more than half of individuals age 80 and over suffer from this condition. In a recent study released in JAMA Ophthalmology, it was confirmed that statins, which are typically prescribed to reduce cholesterol and also prevent heart disease, may cause an increased risk for cataracts among individuals ages 30 through 85.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roberto De Giorgio, LAMFT 747 E 2200 S, Clearfield, UT 84015-6237 Ph: () - | Roberto De Giorgio, LAMFT 934 S Main St, Layton, UT 84041-7135 Ph: (801) 233-8607 |
News Archive
Vitamin D deficiency - which is traditionally associated with bone and muscle weakness - may also increase the risk of cardiovascular disease (CVD).
Synexus has completed a phase II study for the European biotech, Creabilis, recruiting 26 patients in the UK to the psoriasis trial of its CT327 lead product in just 2 weeks, as part of an international proof-of-concept study. The company delivered the targeted number of patients well within the agreed timelines and budget.
In the study, the scientists screened known drugs and identified small molecules that could replace conventional reprogramming genes, which can have dangerous side effects.
Competitive Technologies, Inc. today announced the presentation of results from a study that shows the successful treatment of patients suffering from pain associated with chemotherapy-induced peripheral neuropathy using CTT's Calmare Pain Therapy Treatment. A three-hour discussion led by principal investigator, Thomas J. Smith, M.D., Endowed Chair of Palliative Care Research and Medical Director of the Thomas Palliative Care Unit Virginia Commonwealth University's Massey Cancer Center, at the American Society of Clinical Oncology Annual Meeting, cited results of the study.
According to the Centers for Disease Control and Prevention, cataracts are the number one cause of vision loss in the United States. Nearly 22 million Americans age 40 and over have cataracts, while more than half of individuals age 80 and over suffer from this condition. In a recent study released in JAMA Ophthalmology, it was confirmed that statins, which are typically prescribed to reduce cholesterol and also prevent heart disease, may cause an increased risk for cataracts among individuals ages 30 through 85.
› Verified 4 days ago
Ms. Marilyn D Stephens-burton, LMFT, M.A Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 930 W Hill Field Road, Suite A, Layton, UT 84041 Phone: 801-336-3040 Fax: 801-336-3041 | |
Brian Reeves, LAMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-336-1845 | |
Matthew Lefthand, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1730 E 3100 N Ste 2, Layton, UT 84040 Phone: 801-458-0665 | |
Nefily Ledezma, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 Fax: 801-336-1787 | |
Daniel Stuart, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 930 W Hill Field Rd, Layton, UT 84041 Phone: 801-913-8790 | |
Amanda Van Leeuwen Jenks, MFT INTERN Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1660 W Antelope Dr Ste 301, Layton, UT 84041 Phone: 435-213-9278 | |
Alexis Anne Lee, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1650 W Gentile St, Layton, UT 84041 Phone: 801-485-8051 |